Research on "VIC" business model of research and development of innovative drugs
ZHAO Dan
YAN Jian-zhou
SHAO Rong
Abstract：The lack of venture capital, loss of intellectual property rights and stagnation of outsourcing research and development ( R&D) industry set a serious impediment to the development of China's pharmaceutical innovation industry. This paper argues that the business model of "venture capital-intellectual property-contract research organization" ( VC + IP + CRO, VIC) can promote the sustainable development of innovative drugs in China. On this basis, this paper analyzes the causes, operating mechanism and advantages and disadvantages of the model, and proves the operability of this model with cases. Finally, the paper puts forward some suggestions to promote the development of "VIC"business model in the new drugs R&D in China.
Keywords：innovative drugintellectual propertyventure capitalresearch and development outsourcingbusiness modelcase analysis
Publication Date：2018-01-01
Online Publishing Date：2026-08-14(First online date of this platform, not the publication date of the document)
Pages：5( 1830-1834 )